Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Philadelphia Positive Chronic Myeloid Leukemia”

214 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 214 results

Post-approval studies (Phase 4)Study completedNCT01061177
What this trial is testing

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Who this might be right for
CML in Chronic Phase
Novartis Pharmaceuticals 1,090
Testing effectiveness (Phase 2)Study completedNCT00858806
What this trial is testing

Intermittent Imatinib Treatment in Chronic Myeloid Leukemia and Philadelphia Chromosome (Ph+CML) Patients Who Achieved a Complete Cytogenetic Response (CCgR) on Standard Imatinib Therapy

Who this might be right for
Chronic Myeloid Leukemia
Università degli Studi di Brescia 78
Testing effectiveness (Phase 2)Ended earlyNCT01357655
What this trial is testing

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Who this might be right for
Leukemia
Bristol-Myers Squibb 70
Not applicableEnded earlyNCT00008216
What this trial is testing

Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Adult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more
Columbia University 48
Testing effectiveness (Phase 2)UnknownNCT02885766
What this trial is testing

Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene

Who this might be right for
Chronic Myeloid LeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive
Fusion Pharma LLC 65
Post-approval studies (Phase 4)Study completedNCT01227577
What this trial is testing

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Who this might be right for
Chronic Myelogenous Leukemia in Chronic Phase
Novartis Pharmaceuticals 128
Testing effectiveness (Phase 2)Study completedNCT00004181
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMultiple Myeloma and Plasma Cell Neoplasm
Northwestern University
Early research (Phase 1)Study completedNCT00005092
What this trial is testing

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
M.D. Anderson Cancer Center 7
Not applicableApproved For MarketingNCT01592136
What this trial is testing

Expanded Access Program of Ponatinib

Who this might be right for
Chronic Myeloid Leukemia (CML)Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Ariad Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT03241199
What this trial is testing

The Efficacy and Safety of Induction-Maintenance Protocol for Patients With Chronic Myelogenous Leukaemia

Who this might be right for
Chronic Myeloid LeukemiaPhiladelphia Chromosome Positive CML
The University of Hong Kong 15
Not applicableStudy completedNCT01215487
What this trial is testing

A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With Imatinib

Who this might be right for
Chronic Myeloid Leukemia
University of British Columbia 68
Large-scale testing (Phase 3)Study completedNCT01535391
What this trial is testing

Nilotinib in PH+, BCR-, ABL+ CML Patients

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 109
Early research (Phase 1)Study completedNCT00352677
What this trial is testing

Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphocytic Leukemia
CytRx 100
Large-scale testing (Phase 3)UnknownNCT00966810
What this trial is testing

Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion

Who this might be right for
Philadelphia Chromosome-positive Chronic Myelocytic Leukemia
Rambam Health Care Campus 40
Early research (Phase 1)Study completedNCT00422825
What this trial is testing

Effect of Food on Bioavailability of a Modified Release Formulation of Imatinib

Who this might be right for
Healthy
Novartis Pharmaceuticals 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07493408
What this trial is testing

Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML

Who this might be right for
Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)Blastic Transformation of Chronic Myeloid LeukemiaPhiladelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (Ph+ B-ALL)+1 more
The University of Hong Kong
Testing effectiveness (Phase 2)Ended earlyNCT00022490
What this trial is testing

Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
OHSU Knight Cancer Institute 24
Large-scale testing (Phase 3)Study completedNCT01254188
What this trial is testing

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 421
Testing effectiveness (Phase 2)Study completedNCT00109707
What this trial is testing

Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Hypereosinophilic Syndrome+1 more
Novartis Pharmaceuticals 507
Large-scale testing (Phase 3)Study completedNCT00265837
What this trial is testing

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72
Load More Results
45